exatecan C'Dot drug conjugate (Elucida Oncology)

N/A

Report date: 2025/06/11 11:24:12
NME

Base Information

Drug Nameexatecan C'Dot drug conjugate (Elucida Oncology)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElucida Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesElucida Oncology Inc
Inactive CompaniesN/A
Active IndicationsNeoplasm Metastasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A